PL430531A1 - Podłoże oraz kompozycja farmaceutyczna je zawierająca - Google Patents

Podłoże oraz kompozycja farmaceutyczna je zawierająca

Info

Publication number
PL430531A1
PL430531A1 PL430531A PL43053119A PL430531A1 PL 430531 A1 PL430531 A1 PL 430531A1 PL 430531 A PL430531 A PL 430531A PL 43053119 A PL43053119 A PL 43053119A PL 430531 A1 PL430531 A1 PL 430531A1
Authority
PL
Poland
Prior art keywords
weight
drug
group
fatty acids
pharmaceutical
Prior art date
Application number
PL430531A
Other languages
English (en)
Inventor
Paweł BIERNAT
Jan MELER
Konrad Krajewski
Dawid BURSY
Original Assignee
Biotts Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotts Spółka Akcyjna filed Critical Biotts Spółka Akcyjna
Priority to PL430531A priority Critical patent/PL430531A1/pl
Priority to EP20837275.5A priority patent/EP3996677A4/en
Priority to PCT/PL2020/050050 priority patent/WO2021006753A1/en
Priority to US16/963,532 priority patent/US20210401817A1/en
Publication of PL430531A1 publication Critical patent/PL430531A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Abstract

Przedmiotem zgłoszenia jest podłoże farmaceutyczne dla znieczulających substancji czynnych charakteryzujące się tym, że zawiera silnie solwatujący rozpuszczalnik aprotyczny z grupy sulfotlenków w ilości od 0,25% do 15% masy leku, amid kwasu węglowego w ilości od 1% do 5% masy leku, oraz tłuszcz zwierzęcy o zawartości nienasyconych kwasów tłuszczowych do około 55%, organiczny związek chemiczny z grupy alkoholi dwuhydroksylowych od 5% do 15% masy leku, organiczny związek chemiczny z grupy alkoholi alifatycznych od 0,05% do 1,5% masy leku, organiczny związek chemiczny z grupy jednonienasyconych kwasów tłuszczowych typu omega-9 od 2% do 10% masy leku. Zgłoszenie obejmuje też kompozycję farmaceutyczną, charakteryzującą się tym, że zawiera powyższe podłoże oraz substancje czynne, przy czym stosunek wagowy substancji pomocniczych bezwodne, farmaceutyczne podłoże maściowe do smalcu wieprzowego wynosi od 1:2 do 2:1 a proporcja wagowa mieszaniny alkoholu izopropylowego i glikolu wynosi od 1:5 do 1:15 i zawiera dimetylosulfotlenek w zakresie od 0,25% do 15% masy kompozycji.
PL430531A 2019-07-09 2019-07-09 Podłoże oraz kompozycja farmaceutyczna je zawierająca PL430531A1 (pl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL430531A PL430531A1 (pl) 2019-07-09 2019-07-09 Podłoże oraz kompozycja farmaceutyczna je zawierająca
EP20837275.5A EP3996677A4 (en) 2019-07-09 2020-07-09 BASE AND PHARMACEUTICAL COMPOSITION CONTAINING IT
PCT/PL2020/050050 WO2021006753A1 (en) 2019-07-09 2020-07-09 A base and a pharmaceutical composition containing it
US16/963,532 US20210401817A1 (en) 2019-07-09 2020-07-09 Podloze oraz kompozycja farmaceutyczna je zawierajaca

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL430531A PL430531A1 (pl) 2019-07-09 2019-07-09 Podłoże oraz kompozycja farmaceutyczna je zawierająca

Publications (1)

Publication Number Publication Date
PL430531A1 true PL430531A1 (pl) 2021-01-11

Family

ID=74114727

Family Applications (1)

Application Number Title Priority Date Filing Date
PL430531A PL430531A1 (pl) 2019-07-09 2019-07-09 Podłoże oraz kompozycja farmaceutyczna je zawierająca

Country Status (4)

Country Link
US (1) US20210401817A1 (pl)
EP (1) EP3996677A4 (pl)
PL (1) PL430531A1 (pl)
WO (1) WO2021006753A1 (pl)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB315306A (en) * 1928-07-11 1930-05-08 Chem Fab Vormals Sandoz Improvements in the preparation of anti-inflammatory and soothing ointments
DE3811461A1 (de) * 1987-04-23 1988-11-03 Christina Rada Koerperbehandlungsmittel zur pflege der koerperhaut
US5814659A (en) * 1996-04-23 1998-09-29 Dtr Dermal Therapy (Barbados) Inc. Topical analgesic composition
US6673363B2 (en) * 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6638981B2 (en) * 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
ES2223277B1 (es) * 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
UA83402C2 (en) * 2006-07-06 2008-07-10 Светлана Владимировна Бабий Anti-inflammatory analgesic ointment

Also Published As

Publication number Publication date
EP3996677A4 (en) 2023-08-02
WO2021006753A1 (en) 2021-01-14
US20210401817A1 (en) 2021-12-30
EP3996677A1 (en) 2022-05-18

Similar Documents

Publication Publication Date Title
WO2014042043A1 (en) Pharmaceutical composition containing luliconazole
ES2625268T3 (es) Composición farmacéutica que comprende un derivado de amida que inhibe el crecimiento de las células cancerosas y un lubricante de una sal no metálica
KR101651448B1 (ko) 체지방을 국소적으로 증가시키는 방법 및 조성물
CN1237106A (zh) 含有4,5－环氧吗啡喃衍生物的稳定的药物组合物
ATE318598T1 (de) Antioxidierende stabilisierungssysteme für pharmazeutische formulierungen
US10568890B2 (en) Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method thereof
RU2009127500A (ru) Фармацевтические композиции и способ лечения воспаления у крупного рогатого скота и других животных
WO2011028629A1 (en) Pharmaceutical formulations and methods of use
EP2699231B1 (en) Suspension type topical formulations comprising cyclic depsipeptide
WO2007065026A3 (en) Fatty acid ester blends as carriers for pesticide active ingredients
RU2017111503A (ru) КОМПОЗИЦИИ(17-β)-3-ОКСОАНДРОСТ-4-ЕН-17-ИЛ УНДЕКАНОАТА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
Stella Chemical drug stability in lipids, modified lipids, and polyethylene oxide-containing formulations
AU2010275240A1 (en) Topical pharmaceutical composition including rel-N- [6 - [ (2R, 6S) - 2, 6 - dimethyl - 4 -morpholinyl] -3 - pyridinyl] - 2 -methyl -41 (trifluoromethoxy) - [1,1' -biphenyl] - 3 - carboxamide
AU2014260509B2 (en) Topical composition and carrier for administration of pharmaceutically or cosmetically active ingredients
JP6742487B1 (ja) エルデカルシトール含有医薬組成物
US6169113B1 (en) Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
PL430531A1 (pl) Podłoże oraz kompozycja farmaceutyczna je zawierająca
US10227321B2 (en) Soothing pro-pheromonal composition for mammals
US20160058721A1 (en) Formulation for treating equine inflammation
TW201919584A (zh) 用於動物寄生蟲之防治及預防的可局部投予之調配物
JPS52133939A (en) Preparation of 2-substituted benzanilides
US20190241498A1 (en) Resveratrol esters
KR20160081975A (ko) 참기름을 베이스로 하는 주사 제제
JPS6353967B2 (pl)
CA3037593A1 (en) Pharmaceutical composition comprising polyunsaturated long-chain ketones in a silicone vehicle